Waving Goodbye to the X Waiver: Reassessing Medication Treatment for Opioid Use Disorder

<p>Tanner Melton, PharmD reviews literature on buprenorphine and methadone in treating opioid use disorder.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes.</a></p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>